ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    NK Cells Are Associated with Alloimmune Failure in Transplanted Children

    E. T. Chambers1, O. Martinez2, M. Robien3, C. Chan1, R. Ettenger4, P. Grimm5, H. Lee1, E. Reed4, L. Stempora6, M. Sarwal7, B. Warshaw8, C. Zhao1, A. D. Kirk6

    1Pediatrics, Duke University, Durham, NC, 2Surgery, Stanford, Palo Alto, CA, 3NIH, Bethesda, MD, 4Pediatrics, UCLA, Los Angeles, CA, 5Pediatrics, Stanford, Stanford, CA, 6Surgery, Duke University, Durham, NC, 7Pediatrics, UCSF, San Francisco, CA, 8Pediatrics, Emory University, Atlanta, GA

    *Purpose: Alloimmune failure, defined as the development of donor specific antibody (DSA) and/ or allograft rejection, remains a significant complication in pediatric kidney transplantation. NK…
  • 2019 American Transplant Congress

    Apoptotic Exosome-Like Vesicles Induce Endothelial Cell Plasticity and Accelerate Allograft Vascular Remodeling

    F. Migneault1, M. Dieudé1, J. Turgeon1, A. Karakeussian Rimbaud1, D. Beillevaire1, M. Hardy2, A. Brodeur1, N. Thibodeau1, C. Perreault2, M. Hébert1

    1CRCHUM, Montreal, QC, Canada, 2IRIC, Montreal, QC, Canada

    *Purpose: Acute vascular rejection of allografts is associated with endothelial apoptosis which in turn contributes to the development of transplant vasculopathy. We previously showed that…
  • 2019 American Transplant Congress

    Preliminary Mechanistic Studies of Regulatory Dendritic Cell (DCreg) Cell Infusion in Living Donor Liver Transplant Recipients

    A. Thomson, C. Macedo, A. Zahorchak, H. Dai, A. Humar, F. G. Lakkis, M. Styn, D. Metes

    Starzl Transplantation Institute, Pittsburgh, PA

    *Purpose: This is a first-in-human phase I/II safety and preliminary efficacy trial of donor-derived regulatory dendritic cells (DCreg) in living donor liver transplantation (LTx) in…
  • 2019 American Transplant Congress

    Efficacy and Safety Outcomes with De Novo Use of Everolimus-Based Regimen in Renal Transplant Recipients with Delayed Graft Function from the TRANSFORM Study

    S. Chadban1, F. Oppenheimer1, F. Citterio1, O. Witzke1, V. D. Garcia1, A. Gutierrez-Dalmau1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, A. Wiseman1

    1TRANSFORM Study Group, Basel, Switzerland, 2Novartis Pharma AG, Basel, Switzerland

    *Purpose: To evaluate the effect of everolimus with reduced CNI (EVR+rCNI) vs mycophenolic acid with standard CNI (MPA+sCNI) on efficacy and safety outcomes in RTxR…
  • 2019 American Transplant Congress

    Long-Term Outcomes in Patients with Obesity and Renal Disease after Sleeve Gastrectomy

    A. Kassam, A. Mirza, Y. Kim, E. S. Woodle, S. A. Shah, M. C. Cuffy, R. C. Quillin III, L. Sage Silski, A. Govil, M. Cardi, T. S. Diwan

    Department of Surgery, University of Cincinnati, Cincinnati, OH

    *Purpose: Morbid obesity is a barrier to kidney transplantation in patients with end-stage renal disease (ESRD) and is associated with progression of chronic kidney disease…
  • 2019 American Transplant Congress

    Effect of Everolimus with Reduced-Exposure Tacrolimus and Early Steroid Elimination in Pediatric Kidney Transplant Recipients: 36-Month Outcomes from the CRADLE Study

    H. Tedesco Silva1, R. Ettenger1, A. Bjerre1, M. Christian1, L. Dello Strologo1, S. D. Marks1, L. Pape1, P. Lopez2, M. Cousin2, P. Pandey2, B. Rauer2, M. Meier2, B. Tönshoff1

    1A2314 Study Group, Basel, Switzerland, 2Novartis Pharma AG, Basel, Switzerland

    *Purpose: To compare 36-month (M) efficacy and safety outcomes of an everolimus+reduced-exposure tacrolimus (EVR+rTAC)+steroids (CS) withdrawal regimen vs mycophenolate mofetil+standard-exposure TAC (MMF+sTAC)+CS in pediatric kidney…
  • 2019 American Transplant Congress

    Targeting Cell Metabolism for Efficient Large-Scale Expansion of Functional Regulatory T Cells

    R. Gedaly-Eidelman, F. Marti, L. Turcios, E. Chacon, D. Valvi

    University of Kentucky, Lexington, KY

    *Purpose: A growing body of evidence recognizes the balance between graft-reactive effector T cells and graft-protective regulatory T cells (Tregs) as the ultimate determinant of…
  • 2019 American Transplant Congress

    Decay Accelerating Factor (DAF) Regulates Germinal Center B-cell and Alloantibody Formation

    A. Cumpelik1, G. Varano2, D. Heja1, D. Homann3, S. Lira4, D. Dominguez-Sola2, P. S. Heeger1

    1Nephrology, Mount Sinai School of Medicine, New York, NY, 2Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, 3Medicine, Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, NY, 4Clinical Immunology, Mount Sinai School of Medicine, New York, NY

    *Purpose: High affinity IgG antibodies including alloantibodies result from germinal center (GC) reactions in which somatic hypermutation and positive selection cause affinity maturation. When we…
  • 2019 American Transplant Congress

    Belatacept Treated Patients Experience Improved Health-Related Quality of Life and Lower Symptom Distress Compared to Cyclosporine Treated Patients: An Analysis of the Benefit and Benefit-EXT Cohorts

    M. J. Everly1, I. Purnajo1, J. L. Beaumont1, M. Polinsky2, E. Alemao2

    1Terasaki Research Institute, Los Angeles, CA, 2Bristol Myers Squibb, Princeton, NJ

    *Purpose: New immunosuppressive agents in transplant should not only be efficacious but also help patients feel better (i.e. lower patient reported symptoms and improve health…
  • 2019 American Transplant Congress

    Belatacept Based CNI Free Immunosuppression in Pancreas Transplantation. Results at 4 Years

    J. Chen, J. Fridell, M. Yaqub, T. Taber, D. MIshler, O. Adebiyi, M. Mujtaba, A. Sharfuddin

    Indiana University School of Medicine, Indianapolis, IN

    *Purpose: CNI based Immunosuppression is a well known risk factor for worsening renal function. We report our experience in converting Pancreas Transplant recipients from tacrolimus…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences